18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: Analysis of a multicenter study

Kotaro Higashi, Kengo Ito, Yoshinori Hiramatsu, Tsutomu Ishikawa, Tsutomu Sakuma, Ichiro Matsunari, Gencho Kuga, Katsuyuki Miura, Takahiro Higuchi, Hisao Tonami, Itaru Yamamoto

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Intratumoral lymphatic vessel invasion and lymph node involvement are important factors in the planning of therapeutic strategies, particularly limited surgical resection in patients with non-small cell lung cancer. 18F-FDG uptake within the primary lesion correlates with aggressiveness on PET studies. The more metabolically active the tumor, the more aggressive are the findings. The aim of this multicenter study was to determine whether 18F-FDG uptake of the primary tumor is a predictor of intratumoral lymphatic vessel invasion and lymph node metastasis in patients with non-small cell lung cancer. Methods: One hundred thirty-two patients with lung cancer were studied. All patients underwent a thoracotomy within 4 wk of the 18F-FDG PET study. A 3-point visual scoring system (low, moderate, or high grade in comparison with mediastinal activity) was used to interpret 18F-FDG uptake within the primary lesions. The degree of 18F-FDG uptake in the primary tumor was correlated with the incidence of intratumoral lymphatic vessel invasion and lymph node involvement. Multivariate analysis was performed with logistic multivariate analysis to assess the joint effects and interactions of the variables (age, sex, tumor size, histology, and 18F-FDG uptake) on intratumoral lymphatic vessel invasion and lymph node involvement. Results: Intratumoral lymphatic vessel invasion and lymph node involvement were found in 7.1% and 5.9%, respectively, of the patients classified in the low-grade group, and in 14.3% and 10.0%, respectively, of the patients classified in the moderate-grade group. In contrast, of the patients classified in the group with high 18F-FDG uptake, intratumoral lymphatic vessel invasion and lymph node involvement were found in 39.7% and 38.9%, respectively. Multivariate analysis showed that only 18F-FDG uptake was a significant factor for intratumoral lymphatic vessel invasion and that tumor size and 18F-FDG uptake were significant factors for lymph node involvement. Of the patients in the high-grade group whose tumors were classified as ≥3 cm in size, lymph node involvement was found in 51.5%. In contrast, of the patients in the low-to moderate-grade group whose tumors were classified as <3 cm in size, lymph node involvement was found in only 9.1% (P < 0.0001). Conclusion: Patients with a low to moderate 18F-FDG uptake in the primary lesion had a significantly lower risk of concurrent intratumoral lymphatic vessel invasion and nodal involvement than did patients with a high 18F-FDG uptake. In patients with non-small cell lung cancer, 18F-FDG uptake by the primary tumor is a strong predictor of intratumoral lymphatic vessel invasion and lymph node metastasis.

Original languageEnglish
Pages (from-to)267-273
Number of pages7
JournalJournal of Nuclear Medicine
Volume46
Issue number2
Publication statusPublished - Dec 1 2005
Externally publishedYes

Fingerprint

Lymphatic Vessels
Fluorodeoxyglucose F18
Non-Small Cell Lung Carcinoma
Multicenter Studies
Lymph Nodes
Neoplasms
Multivariate Analysis
Lymphatic Vessel Tumors
Neoplasm Metastasis
Thoracotomy
Lung Neoplasms
Histology

Keywords

  • F-FDG PET
  • Lung cancer
  • Nodal involvement

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer : Analysis of a multicenter study. / Higashi, Kotaro; Ito, Kengo; Hiramatsu, Yoshinori; Ishikawa, Tsutomu; Sakuma, Tsutomu; Matsunari, Ichiro; Kuga, Gencho; Miura, Katsuyuki; Higuchi, Takahiro; Tonami, Hisao; Yamamoto, Itaru.

In: Journal of Nuclear Medicine, Vol. 46, No. 2, 01.12.2005, p. 267-273.

Research output: Contribution to journalArticle

Higashi, K, Ito, K, Hiramatsu, Y, Ishikawa, T, Sakuma, T, Matsunari, I, Kuga, G, Miura, K, Higuchi, T, Tonami, H & Yamamoto, I 2005, '18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: Analysis of a multicenter study', Journal of Nuclear Medicine, vol. 46, no. 2, pp. 267-273.
Higashi, Kotaro ; Ito, Kengo ; Hiramatsu, Yoshinori ; Ishikawa, Tsutomu ; Sakuma, Tsutomu ; Matsunari, Ichiro ; Kuga, Gencho ; Miura, Katsuyuki ; Higuchi, Takahiro ; Tonami, Hisao ; Yamamoto, Itaru. / 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer : Analysis of a multicenter study. In: Journal of Nuclear Medicine. 2005 ; Vol. 46, No. 2. pp. 267-273.
@article{b6005b66b0424b9dabdcfc0981efc855,
title = "18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: Analysis of a multicenter study",
abstract = "Intratumoral lymphatic vessel invasion and lymph node involvement are important factors in the planning of therapeutic strategies, particularly limited surgical resection in patients with non-small cell lung cancer. 18F-FDG uptake within the primary lesion correlates with aggressiveness on PET studies. The more metabolically active the tumor, the more aggressive are the findings. The aim of this multicenter study was to determine whether 18F-FDG uptake of the primary tumor is a predictor of intratumoral lymphatic vessel invasion and lymph node metastasis in patients with non-small cell lung cancer. Methods: One hundred thirty-two patients with lung cancer were studied. All patients underwent a thoracotomy within 4 wk of the 18F-FDG PET study. A 3-point visual scoring system (low, moderate, or high grade in comparison with mediastinal activity) was used to interpret 18F-FDG uptake within the primary lesions. The degree of 18F-FDG uptake in the primary tumor was correlated with the incidence of intratumoral lymphatic vessel invasion and lymph node involvement. Multivariate analysis was performed with logistic multivariate analysis to assess the joint effects and interactions of the variables (age, sex, tumor size, histology, and 18F-FDG uptake) on intratumoral lymphatic vessel invasion and lymph node involvement. Results: Intratumoral lymphatic vessel invasion and lymph node involvement were found in 7.1{\%} and 5.9{\%}, respectively, of the patients classified in the low-grade group, and in 14.3{\%} and 10.0{\%}, respectively, of the patients classified in the moderate-grade group. In contrast, of the patients classified in the group with high 18F-FDG uptake, intratumoral lymphatic vessel invasion and lymph node involvement were found in 39.7{\%} and 38.9{\%}, respectively. Multivariate analysis showed that only 18F-FDG uptake was a significant factor for intratumoral lymphatic vessel invasion and that tumor size and 18F-FDG uptake were significant factors for lymph node involvement. Of the patients in the high-grade group whose tumors were classified as ≥3 cm in size, lymph node involvement was found in 51.5{\%}. In contrast, of the patients in the low-to moderate-grade group whose tumors were classified as <3 cm in size, lymph node involvement was found in only 9.1{\%} (P < 0.0001). Conclusion: Patients with a low to moderate 18F-FDG uptake in the primary lesion had a significantly lower risk of concurrent intratumoral lymphatic vessel invasion and nodal involvement than did patients with a high 18F-FDG uptake. In patients with non-small cell lung cancer, 18F-FDG uptake by the primary tumor is a strong predictor of intratumoral lymphatic vessel invasion and lymph node metastasis.",
keywords = "F-FDG PET, Lung cancer, Nodal involvement",
author = "Kotaro Higashi and Kengo Ito and Yoshinori Hiramatsu and Tsutomu Ishikawa and Tsutomu Sakuma and Ichiro Matsunari and Gencho Kuga and Katsuyuki Miura and Takahiro Higuchi and Hisao Tonami and Itaru Yamamoto",
year = "2005",
month = "12",
day = "1",
language = "English",
volume = "46",
pages = "267--273",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "2",

}

TY - JOUR

T1 - 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer

T2 - Analysis of a multicenter study

AU - Higashi, Kotaro

AU - Ito, Kengo

AU - Hiramatsu, Yoshinori

AU - Ishikawa, Tsutomu

AU - Sakuma, Tsutomu

AU - Matsunari, Ichiro

AU - Kuga, Gencho

AU - Miura, Katsuyuki

AU - Higuchi, Takahiro

AU - Tonami, Hisao

AU - Yamamoto, Itaru

PY - 2005/12/1

Y1 - 2005/12/1

N2 - Intratumoral lymphatic vessel invasion and lymph node involvement are important factors in the planning of therapeutic strategies, particularly limited surgical resection in patients with non-small cell lung cancer. 18F-FDG uptake within the primary lesion correlates with aggressiveness on PET studies. The more metabolically active the tumor, the more aggressive are the findings. The aim of this multicenter study was to determine whether 18F-FDG uptake of the primary tumor is a predictor of intratumoral lymphatic vessel invasion and lymph node metastasis in patients with non-small cell lung cancer. Methods: One hundred thirty-two patients with lung cancer were studied. All patients underwent a thoracotomy within 4 wk of the 18F-FDG PET study. A 3-point visual scoring system (low, moderate, or high grade in comparison with mediastinal activity) was used to interpret 18F-FDG uptake within the primary lesions. The degree of 18F-FDG uptake in the primary tumor was correlated with the incidence of intratumoral lymphatic vessel invasion and lymph node involvement. Multivariate analysis was performed with logistic multivariate analysis to assess the joint effects and interactions of the variables (age, sex, tumor size, histology, and 18F-FDG uptake) on intratumoral lymphatic vessel invasion and lymph node involvement. Results: Intratumoral lymphatic vessel invasion and lymph node involvement were found in 7.1% and 5.9%, respectively, of the patients classified in the low-grade group, and in 14.3% and 10.0%, respectively, of the patients classified in the moderate-grade group. In contrast, of the patients classified in the group with high 18F-FDG uptake, intratumoral lymphatic vessel invasion and lymph node involvement were found in 39.7% and 38.9%, respectively. Multivariate analysis showed that only 18F-FDG uptake was a significant factor for intratumoral lymphatic vessel invasion and that tumor size and 18F-FDG uptake were significant factors for lymph node involvement. Of the patients in the high-grade group whose tumors were classified as ≥3 cm in size, lymph node involvement was found in 51.5%. In contrast, of the patients in the low-to moderate-grade group whose tumors were classified as <3 cm in size, lymph node involvement was found in only 9.1% (P < 0.0001). Conclusion: Patients with a low to moderate 18F-FDG uptake in the primary lesion had a significantly lower risk of concurrent intratumoral lymphatic vessel invasion and nodal involvement than did patients with a high 18F-FDG uptake. In patients with non-small cell lung cancer, 18F-FDG uptake by the primary tumor is a strong predictor of intratumoral lymphatic vessel invasion and lymph node metastasis.

AB - Intratumoral lymphatic vessel invasion and lymph node involvement are important factors in the planning of therapeutic strategies, particularly limited surgical resection in patients with non-small cell lung cancer. 18F-FDG uptake within the primary lesion correlates with aggressiveness on PET studies. The more metabolically active the tumor, the more aggressive are the findings. The aim of this multicenter study was to determine whether 18F-FDG uptake of the primary tumor is a predictor of intratumoral lymphatic vessel invasion and lymph node metastasis in patients with non-small cell lung cancer. Methods: One hundred thirty-two patients with lung cancer were studied. All patients underwent a thoracotomy within 4 wk of the 18F-FDG PET study. A 3-point visual scoring system (low, moderate, or high grade in comparison with mediastinal activity) was used to interpret 18F-FDG uptake within the primary lesions. The degree of 18F-FDG uptake in the primary tumor was correlated with the incidence of intratumoral lymphatic vessel invasion and lymph node involvement. Multivariate analysis was performed with logistic multivariate analysis to assess the joint effects and interactions of the variables (age, sex, tumor size, histology, and 18F-FDG uptake) on intratumoral lymphatic vessel invasion and lymph node involvement. Results: Intratumoral lymphatic vessel invasion and lymph node involvement were found in 7.1% and 5.9%, respectively, of the patients classified in the low-grade group, and in 14.3% and 10.0%, respectively, of the patients classified in the moderate-grade group. In contrast, of the patients classified in the group with high 18F-FDG uptake, intratumoral lymphatic vessel invasion and lymph node involvement were found in 39.7% and 38.9%, respectively. Multivariate analysis showed that only 18F-FDG uptake was a significant factor for intratumoral lymphatic vessel invasion and that tumor size and 18F-FDG uptake were significant factors for lymph node involvement. Of the patients in the high-grade group whose tumors were classified as ≥3 cm in size, lymph node involvement was found in 51.5%. In contrast, of the patients in the low-to moderate-grade group whose tumors were classified as <3 cm in size, lymph node involvement was found in only 9.1% (P < 0.0001). Conclusion: Patients with a low to moderate 18F-FDG uptake in the primary lesion had a significantly lower risk of concurrent intratumoral lymphatic vessel invasion and nodal involvement than did patients with a high 18F-FDG uptake. In patients with non-small cell lung cancer, 18F-FDG uptake by the primary tumor is a strong predictor of intratumoral lymphatic vessel invasion and lymph node metastasis.

KW - F-FDG PET

KW - Lung cancer

KW - Nodal involvement

UR - http://www.scopus.com/inward/record.url?scp=15844415321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15844415321&partnerID=8YFLogxK

M3 - Article

C2 - 15695786

AN - SCOPUS:15844415321

VL - 46

SP - 267

EP - 273

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 2

ER -